F. Spyratos
About
In The Last Decade
F. Spyratos
24 papers receiving 380 citations
Peers
Comparison fields: 5 of 54
- Oncology 223
- Cancer Research 206
- Molecular Biology 110
- Pathology and Forensic Medicine 90
- Immunology and Allergy 55
Countries citing papers authored by F. Spyratos
This map shows the geographic impact of F. Spyratos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Spyratos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Spyratos more than expected).
Fields of papers citing papers by F. Spyratos
This network shows the impact of papers produced by F. Spyratos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Spyratos. The network helps show where F. Spyratos may publish in the future.
Co-authorship network of co-authors of F. Spyratos
This figure shows the co-authorship network connecting the top 25 collaborators of F. Spyratos. A scholar is included among the top collaborators of F. Spyratos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Spyratos. F. Spyratos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 35 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | [Immunohistochemical determination of hormonal receptors on cell-blocks from fine-needle cytopunctures of breast carcinoma]. | 4 |
| 6 | Multivariate analyses of flow cytometric S-phase and ploidy as node-negative breast cancer prognostic factors : an international and multi-center study | 1 |
| 7 | 110 | |
| 8 | [Breast cancer: prognostic value of a dissemination index based on 4 components of the urokinase-type plasminogen activator system]. | 2 |
| 9 | 4 | |
| 10 | 13 | |
| 11 | 1 | |
| 12 | 14 | |
| 13 | Cytologic nuclear grading of fine needle cytopunctures of breast carcinoma. Comparison with histologic nuclear grading and image cytometric data. | 11 |
| 14 | 137 | |
| 15 | Computer assisted image analysis of bladder tumour nuclei for morphonuclear and ploidy assessment. | 4 |
| 16 | [Intra-tissue biological markers in cancers of the breast: current assessment]. | 1 |
| 17 | 5 | |
| 18 | [Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk]. | 3 |
| 19 | Parathyroid hormone related protein (PTHrP) and breast cancer. | 1 |
| 20 | [Quality control of the assay of receptors in human breast tumors]. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.